DrummondWH, PeckhamGJ, FoxWW. The clinical profile of the newborn with persistent hypertension. Clin Pediatr1977;16:335–341.
5.
GersonyWM. Persistence of the fetal circulation. J Pediatr1973;82:1103–1106.
6.
LevinDL, HeymannMJ, KittermanJA, GregoryGA, PhibbsRH, RudolphAM. Persistent pulmonary hypertension of the newborn infant. J Pediatr1976;89:626–630.
7.
RudolphAM. High pulmonary vascular resistance after birth. Clin Pediatr1980;19:585–590.
8.
TodresID, CroneRK, RogersMC, ShannonDC. Swan-Ganz catheterization in the critically ill newborn. Crit Care Med1979;7:330–334.
9.
RiemenschneiderTA, NielsenHC, RuttenbergHD, JaffeRB. Disturbances of the transitional circulation: Spectrum of pulmonary hypertension and myocardial dysfunction. J Pediatr1976;89:622–625.
10.
RoweRD. Abnormal pulmonary vasocontriction in the newborn. Pediatrics1977;59:318–321.
MurphyJD, RabinovitchM, GoldsteinJD, ReidLM. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr1981;98:962–967.
14.
GoldbergSJ, LevyRA, SiassiB, BettenJA. The effects of maternal hypoxia and hyperoxia upon the neonatal pulmonary vasculature. Pediatrics1971;48:528–533.
15.
GersonyWM, MorishimaHO, SaihaS, KohlS, CohenH, BrownW, StanleyJL. The hemodynamic effects of intrauterine hypoxia: An experimental model in newborn lambs. J Pediatr1976;89:631–635.
16.
HarkerLC, KirkpatrickSE, FriedmanWF, BloorCM. Effects of indomethacin on fetal rat lungs: A possible cause of persistent fetal circulation (PFC). Pediatr Res1981;15:147–151.
17.
PerkinRM, LevinDL, ClarkR.Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension. J Pediatr1980;96:721–726.
18.
LevinDL, HymanAI, HeymannMA, RudolphAM. Fetal hypertension and the development of increased pulmonary vascular smooth muscle: A possible mechanism for persisent pulmonary hypertension of the newborn infant. J Pediatr1978;92:265–269.
19.
BaylenBG, EmmanouilidesGC, JuratschCE, YoshidaY, FrenchWJ, CrileyMJ. Main pulmonary artery distension: A potential mechanism for acute pulmonary hypertension in the human newborn infant. J Pediatr1980;96:540–544.
SegallML, GoettzmanBW, SchickJD. Thrombocytopenia and pulmonary hypertension in the perinatal aspiration syndromes. J Pediatr1980;96:727–730.
22.
FoxWW, GewitzMH, DinwiddieR, DrummondW, PeckhamGJ. Pulmonary hypertension in the perinatal aspiration syndromes. Pediatrics1977;59:205–210.
23.
BucciarelliaRL, EganEA, GessnerIH, EitzmanDV. Persistence of fetal cardiopulmonary circulation: One manifestation of transient tachypnea of the newborn. Pediatrics1976;58:192–197.
24.
RiggsR, HirschfeldS, FanaroffA, LiebmanJ, FletcherB, MeyerR.Persistence of fetal circulation syndrome: An echocardiographic study. J Pediatr1977;91:626–631.
25.
TrippME, DrummondWH, HeymannMA, RudolphAM. Hemodynamic effects of pulmonary arterial infusion of vasodilators in newborn lambs. Pediatr Res1980;14:1311–1315.
GoetzmanBW, SunshineP, JohnsonJD, WennbergRP, HackelA, MertenDF, BartolettiAL, SilvermanNH. Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline. J Pediatr1976;89:617–621.
28.
GoetzmanBW, MilsteinJM. Pulmonary vasodilator action of tolazoline. Pediatr Res1979;13:942–944.
29.
DrummondWH, GregoryGA, HeymannMA, PhibbsRA. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr1971;98:603–611.
30.
BernbaumJ, RusselP, GewitzM, FoxW, PeckhamGS. Neurodevelopment and cardiorespiratory follow-up of infants with PPHN. Pediatr Res1981;15:651.
